Pulmonx
Todd Galski's work experience includes being a Senior Regional Business Director at Pulmonx Corporation since February 2021. Previously, they were a National Sales Director at Guerbet from October 2018 to August 2020, where they led and developed the Interventional Imaging division. Before that, they worked as an Area Sales Manager at Sonendo, Inc. from October 2017 to November 2018. Todd also has experience at AngioDynamics, where they served as a Regional Sales Manager from January 2011 to October 2017 and as a Territory Sales Manager from June 2007 to December 2010. Todd'searlier work experience includes being a Territory Manager at ConMed Endoscopic Technologies from October 2005 to June 2006, and a Senior Sales Representative at GlaxoSmithKline from January 2000 to October 2005.
Todd Galski has a Bachelor of Arts (B.A.) degree in Communication, General from Rutgers University, which they earned between 1992 and 1995. Prior to attending Rutgers, they attended the University of Richmond from 1990 to 1992, but it is unclear whether they obtained a degree or pursued a specific field of study there. In addition to their education, Todd has obtained several certifications from LinkedIn in 2021, including "New RBDs," "Diversity: The Best Resource for Achieving Business Goals," and "Hiring, Managing, and Separating from Employees."
This person is not in any teams
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1